British HIV Association opportunistic infection guidelines: in defence of amphotericin B deoxycholate

HIV Med. 2012 Nov;13(10):636-7. doi: 10.1111/j.1468-1293.2012.01022.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • AIDS-Related Opportunistic Infections / physiopathology
  • Amphotericin B / administration & dosage
  • Amphotericin B / pharmacology*
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / pharmacology*
  • Deoxycholic Acid / administration & dosage
  • Deoxycholic Acid / pharmacology*
  • Drug Administration Schedule
  • Drug Combinations
  • Female
  • Guidelines as Topic
  • HIV Seropositivity / complications
  • HIV Seropositivity / drug therapy*
  • HIV Seropositivity / physiopathology
  • Humans
  • Male
  • Meningitis, Cryptococcal / drug therapy*
  • Meningitis, Cryptococcal / etiology
  • Meningitis, Cryptococcal / physiopathology

Substances

  • Antifungal Agents
  • Drug Combinations
  • Deoxycholic Acid
  • Amphotericin B
  • amphotericin B, deoxycholate drug combination